Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antidepressants
Manufacturing
Lupin recalls nearly 3,000 bottles of OCD drug in US
Mumbai's Lupin has issued a voluntary recall of 2,724 bottles of the tricyclic antidepressant clomiPRAMINE hydrochloride, which is used to treat OCD.
Joseph Keenan
,
Fraiser Kansteiner
Apr 24, 2025 9:48am
Intra-Cellular moves closer to Caplyta depression expansion
Apr 16, 2024 2:27pm
Intra-Cellular's Caplyta posts sweeping win in depression trial
Mar 29, 2023 11:30am
Pharma TV ad spend in 2021: Goodbye Humira, hello Dupixent
Jan 20, 2022 9:35am
AbbVie's Vraylar turns in mixed results in depression
Oct 29, 2021 11:17am
Teva launches first DTC for Austedo into competitive market
May 28, 2021 7:20am